Cargando…
Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae
Since the end of 2019, the global COVID-19 outbreak has once again made coronaviruses a hot topic. Vaccines are hoped to be an effective way to stop the spread of the virus. However, there are no clinically approved vaccines available for coronavirus infections. Reverse genetics technology can reali...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326460/ https://www.ncbi.nlm.nih.gov/pubmed/32711735 http://dx.doi.org/10.1016/bs.aivir.2020.06.003 |
_version_ | 1783552348319121408 |
---|---|
author | Ma, Zhiqian Li, Zhiwei Dong, Linfang Yang, Ting Xiao, Shuqi |
author_facet | Ma, Zhiqian Li, Zhiwei Dong, Linfang Yang, Ting Xiao, Shuqi |
author_sort | Ma, Zhiqian |
collection | PubMed |
description | Since the end of 2019, the global COVID-19 outbreak has once again made coronaviruses a hot topic. Vaccines are hoped to be an effective way to stop the spread of the virus. However, there are no clinically approved vaccines available for coronavirus infections. Reverse genetics technology can realize the operation of RNA virus genomes at the DNA level and provide new ideas and strategies for the development of new vaccines. In this review, we systematically describe the role of reverse genetics technology in studying the effects of coronavirus proteins on viral virulence and innate immunity, cell and tissue tropism and antiviral drug screening. An efficient reverse genetics platform is useful for obtaining the ideal attenuated strain to prepare an attenuated live vaccine. |
format | Online Article Text |
id | pubmed-7326460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73264602020-07-01 Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae Ma, Zhiqian Li, Zhiwei Dong, Linfang Yang, Ting Xiao, Shuqi Adv Virus Res Article Since the end of 2019, the global COVID-19 outbreak has once again made coronaviruses a hot topic. Vaccines are hoped to be an effective way to stop the spread of the virus. However, there are no clinically approved vaccines available for coronavirus infections. Reverse genetics technology can realize the operation of RNA virus genomes at the DNA level and provide new ideas and strategies for the development of new vaccines. In this review, we systematically describe the role of reverse genetics technology in studying the effects of coronavirus proteins on viral virulence and innate immunity, cell and tissue tropism and antiviral drug screening. An efficient reverse genetics platform is useful for obtaining the ideal attenuated strain to prepare an attenuated live vaccine. Elsevier Inc. 2020 2020-06-30 /pmc/articles/PMC7326460/ /pubmed/32711735 http://dx.doi.org/10.1016/bs.aivir.2020.06.003 Text en Copyright © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ma, Zhiqian Li, Zhiwei Dong, Linfang Yang, Ting Xiao, Shuqi Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae |
title | Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae |
title_full | Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae |
title_fullStr | Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae |
title_full_unstemmed | Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae |
title_short | Reverse genetic systems: Rational design of coronavirus live attenuated vaccines with immune sequelae |
title_sort | reverse genetic systems: rational design of coronavirus live attenuated vaccines with immune sequelae |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326460/ https://www.ncbi.nlm.nih.gov/pubmed/32711735 http://dx.doi.org/10.1016/bs.aivir.2020.06.003 |
work_keys_str_mv | AT mazhiqian reversegeneticsystemsrationaldesignofcoronavirusliveattenuatedvaccineswithimmunesequelae AT lizhiwei reversegeneticsystemsrationaldesignofcoronavirusliveattenuatedvaccineswithimmunesequelae AT donglinfang reversegeneticsystemsrationaldesignofcoronavirusliveattenuatedvaccineswithimmunesequelae AT yangting reversegeneticsystemsrationaldesignofcoronavirusliveattenuatedvaccineswithimmunesequelae AT xiaoshuqi reversegeneticsystemsrationaldesignofcoronavirusliveattenuatedvaccineswithimmunesequelae |